Findings demonstrate platform-specific variability in polygenic risk scores affecting breast cancer risk stratification.
Our findings demonstrate that platform-specific variability can influence PRS₃₁₃ estimates to potentially reclassify individuals around clinically relevant thresholds.
No takes yet. Share an insight, caveat, or question.
Ho et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: